Pazoo, Inc. CEO Speaks at Cannabis Convention and Subsidiary MA & Associates, LLC Continues Processing Samples

Tuesday, May 2, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

FLORHAM PARK, N.J., May 2, 2017 /PRNewswire/ -- Pazoo, Inc. (OTC Pinks: PZOO)áis pleased to announce that its subsidiary,

MA & Associates, LLC (MA), a cannabis testing lab in Las Vegas has continued to process mock samples, making the necessary adjustments in extraction methods for the different kinds of cannabis products.á Their chromatography
methods are working and they are ensuring the extraction methods yield consistent results in complex cannabis products.áSo far, the lab has processed four types of edibles, oils, and lotion for the first level of samples which will be processed for actual customers.á This week the lab will be starting on wax, additional edibles and other products.

Furthermore, last week on April 22 and 23, the CEO of Pazoo, David Cunic, was a guest speaker at the annual New England Cannabis Convention (NECANN) and was part of the Cannabis Investment & Entrepreneur Panel of Experts at NECANN in Boston, Massachusetts. David offered his forecast on the trajectory of the booming cannabis industry and specifically, the testing lab sector. David also addressed a key issue of varying cannabis regulations. He provided his take on the importance of establishing consistent nationwide cannabis testing requirements to a sold-out room.á By combining an efficient and cost-effective methodology, the MA team can perform the most accurate and efficient testing that is available on the market.á

"Everyone at Pazoo and MA & Associates, LLC takes pride in following the stringent cannabis laboratory testing guidelines, established by the state of Nevada, to ensure every sample test is evaluated carefully so we can provide the most accurate results", said David Cunic, CEO Pazoo. "Cannabis is a medicine, and must be used safely. It's important that with each prescription, patients are aware of the potency so they can better select a mixture that will offer the best medical benefits for their health. With every sample, we carefully examine potency and harmfuláimpurities, such as mold, fungus, pesticides, and more even before the product is sold at legal dispensaries in states where medical marijuana is approved."

About Pazoo, Inc:

Pazoo, Inc. is a company focused on health, wellness and safety. Our focus is to provide best-in-class laboratory testing of cannabis and cannabinoids to protect consumers from impurities, contaminants and other irregularities. Through our wholly owned subsidiaries, Harris Lee and MA & Associates, Pazoo provides industry leading laboratory testing of cannabis. Pazoo is licensed to test cannabis in Nevada, with a focus on expansion into other states. Additionally, Pazoo delivers a comprehensive array of health and wellness information on its website, and features industry experts from both the health and wellness arena and the pet industry. Lastly, our newly formed wholly owned subsidiary CK Distribution LLC, provides the marketing and sales agent for the distribution of non-controlled hemp products throughout the USA. Non-controlled hemp products are the items utilized by the industry that support grow facilities, infusion companies and dispensaries.

Safe Harbor Statement:

This update includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as Pazoo, Inc. or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statement.


To view the original version on PR Newswire, visit:

SOURCE Pazoo, Inc.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store